Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Tela Bio Inc is a medical devices business based in the US. Tela Bio shares (TELA) are listed on the NASDAQ and all prices are listed in US Dollars. Tela Bio employs 123 staff and has a trailing 12-month revenue of around $34.7 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Active traders
| Latest market close | $8.56 |
|---|---|
| 52-week range | $5.15 - $14.00 |
| 50-day moving average | $8.41 |
| 200-day moving average | $9.72 |
| Wall St. target price | $18.80 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.49 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $8.56 from 2022-10-03
| 1 week (2022-09-28) | 0.94% |
|---|---|
| 1 month (2022-09-02) | 2.76% |
| 3 months (2022-07-05) | 12.78% |
| 6 months (2022-04-04) | -23.91% |
| 1 year (2021-10-05) | -35.05% |
|---|---|
| 2 years (2020-10-05) | -46.80% |
| 3 years (2019-10-01) | N/A |
| 5 years (2017-10-01) | N/A |
| Revenue TTM | $34.7 million |
|---|---|
| Gross profit TTM | $19.1 million |
| Return on assets TTM | -34.92% |
| Return on equity TTM | -242.28% |
| Profit margin | -116.8% |
| Book value | $0.69 |
| Market capitalisation | $164 million |
TTM: trailing 12 months
We're not expecting Tela Bio to pay a dividend over the next 12 months.
Over the last 12 months, Tela Bio's shares have ranged in value from as little as $5.15 up to $14. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tela Bio's is 1.4145. This would suggest that Tela Bio's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
TELA Bio, Inc. , a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. .
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.